Cellect Biotechnology Ltd. – American Depositary Shares (APOP) Given a $14.00 Price Target by HC Wainwright Analysts

Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) has been given a $14.00 target price by stock analysts at HC Wainwright in a research note issued on Friday. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 42.71% from the company’s current price.

Separately, ValuEngine downgraded Cellect Biotechnology Ltd. – American Depositary Shares from a “hold” rating to a “sell” rating in a research report on Friday, December 1st.

Shares of Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) opened at $9.81 on Friday. The company has a market capitalization of $38.73, a price-to-earnings ratio of -14.64 and a beta of 6.07. Cellect Biotechnology Ltd. – American Depositary Shares has a 12-month low of $2.94 and a 12-month high of $13.50.

An institutional investor recently bought a new position in Cellect Biotechnology Ltd. – American Depositary Shares stock. Susquehanna International Group LLP acquired a new stake in Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,764 shares of the company’s stock, valued at approximately $101,000. Susquehanna International Group LLP owned approximately 0.23% of Cellect Biotechnology Ltd. – American Depositary Shares as of its most recent SEC filing. Institutional investors and hedge funds own 0.69% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3126782/cellect-biotechnology-ltd-american-depositary-shares-apop-given-a-14-00-price-target-by-hc-wainwright-analysts.html.

Cellect Biotechnology Ltd. – American Depositary Shares Company Profile

Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel. It is developing the Apotainer selection kit, a shelf stem cell selection kit, based on its Powered by Cellect technology platform for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies.

Receive News & Ratings for Cellect Biotechnology Ltd. - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellect Biotechnology Ltd. - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2018 Ticker Report. Google+.